Wanbury Limited (NSE:WANBURY)
India · Delayed Price · Currency is INR 254.30
+0.95 (0.37%)
May 8, 2026, 3:29 PM IST
Wanbury Market Cap
Wanbury has a market cap or net worth of 8.79 billion as of May 8, 2026. Its market cap has increased by 2.83% in one year.
Market Cap
8.79B
Enterprise Value
10.65B
Revenue
6.58B
Ranking
n/a
PE Ratio
13.59
Stock Price
254.30
Market Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 8.79B, an increase of 397.39%. That is a compound annual growth rate of 7.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 8.79B | 10.94% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 31.82B |
| Solara Active Pharma Sciences | 24.14B |
| Indoco Remedies | 19.87B |
| Windlas Biotech | 18.14B |
| Sakar Healthcare | 14.01B |
| Jagsonpal Pharmaceuticals | 13.90B |
| Beta Drugs | 13.32B |
| Ind-Swift Laboratories | 12.43B |